Why Invest The Ortivus Share Ortivus’ Investors Financial reports Subscribe IR Calendar

Investor relations

Financial information

Read our latest press releases, financial reports and annual meeting materials.

Why Invest

The digitalisation of healthcare will be crucial able to meet the healthcare requirements of the future. In addition to the challenges that Covid-19 has brought with it, we are now seeing increasing patient volumes and limited financial resources in the healthcare sector. For an efficient and safe care, we need new ways of working and new technical innovations. As part of the development, more and more ambulance operations are switching over to electronic patient records and introducing systems that allow patient information to be shared in real time throughout the care chain. Primary care has also begun to implement solutions to be able to monitor and treat patients remotely to a greater extent. Developments in this segment for modern e-health solutions are progressing and are expected to accelerate in the coming years.

Ortivus has in-house development and production of monitoring equipment and is well equipped to meet the requirements of modern, adaptable and reliable healthcare solutions. With Ortivus’ MobiMed, you can review a patients’ vital sign such as ECG, blood pressure and heart rate in real time and at a distance. MobiMed facilitates diagnosis through advanced decision support and the ability to consult an expert remotely via video call or chat. With MobiMed, treatment can be started at an early stage while unnecessary hospital transports can be avoided as a large part of the care can take place outside the hospital. With its modularity, flexibility and advanced features, MobiMed is well adapted for our future healthcare.

Ortivus is today established in many countries and is well positioned to take MobiMed to an even larger international market.

Ortivus shares have been listed on the NASDAQ Stockholm Small Cap-list since January 2, 1997.

	Stock Symbol	ISIN	Shares Outstanding	Votes/share	Total Number of Votes
Class A	ORTI A	SE0000188930	1,662,682	10	16,626,820
Class B	ORTI B	SE0000123085	42,644,786	1	42,644,786

The share capital is SEK 15,507,614. Share capital is divided between class A and class B shares. The number of shares outstanding is 44,307,468 of which class A amount to 1,662,682 and class B to 42,644,786. Every class A share carries 10 votes and every class B share carries one vote.

Ortivus A

Ortivus B

Hover the mouse over the graphs to see the share price at the corresponding date.

Ortivus’ Investors

Top 10 investors	A-Shares	B-Shares	Number of Shares	Number of Votes	Share of Capital	Share of Votes
Ponderus Invest AB	80 525	11 161 350	11 241 875	11 966 600	25.4%	20.2%
Nordnet Pensionsförsäkring	281 354	3 867 191	4 148 545	6 680 731	9.4%	11.3%
Försäkringsaktiebolaget Avanza Pension	32 528	3 275 484	3 308 012	3 600 764	7.5%	6.1%
Konstantin Papaxanthis	353 400		353 400	3 534 000	0.8%	6.0%
Pär-Ola Adolfsson		2 030 237	2 030 237	2 030 237	4.6%	3.4%
Ing-Marie Fraim		2 006 401	2 006 401	2 006 401	4.5%	3.4%
CBLDN-Phoneix Fund		1 562 336	1 562 336	1 562 336	3.5%	2.6%
Nils-Arne Eriksson		1 550 625	1 550 625	1 550 625	3.5%	2.6%
Raspart Förvaltning AB		1 013 226	1 013 226	1 013 226	2.3%	1.7%
Anna Fuhr		946 018	946 018	946 018	2.1%	1.6%
Other	976 554	15 231 918	16 146 793	24 380 668	36.4%	41.1%
Total	1 662 682	42 644 786	44 307 468	59 271 606	100%	100%